ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617394 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617394; 2) Community: the network communities that were significantly associated with the response to NSC 617394; 3) Molecule: the relationships between components within communities and NSC 617394; 4) MDR: the compounds that were significantly associated with the NSC 617394.

NSC Compound Enrichment Correlation
NSC 651855 Null 0.0385613993886001 0.40316628
NSC 654378 Null 0.0385613993886001 0.3307522
NSC 654509 Pirarubicin HCl 0.0385613993886001 0.30656213
NSC 65628 Null 0.0385613993886001 0.23079605
NSC 658088 Null 0.0385613993886001 0.30690257
NSC 668332 Null 0.0385613993886001 0.28499338
NSC 668335 Null 0.0385613993886001 0.46308937
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.0385613993886001 0.33877384
NSC 681643 Camptothecin Derivative 0.0385613993886001 0.13135629
NSC 684496 Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester 0.0385613993886001 0.47628012
Total:130  Current:110    [First] [Prev] [Next] [Last]